Filed before 2025Filed 24 August 2021
Blue Note Therapeutics, Inc. has sold $15.5M so far
Blue Note Therapeutics, Inc., a health care company based in San Francisco, CA, has sold $15.5M so far in its equity round, according to a filing dated 24 August 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 24 August 2021
- First filed
- 12 February 2021
- Round
- Equity round (amended filing)
- Amount sold
- $15.5M
- Offering size
- $50M
- Investors so far
- 4
- Based in
- San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 58% of the 2,220 tracked raises with an amount filed in 2021, and than 58% of the 200 in health care.
Blue Note Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Aug 2021 | Amended filing | $15.5M | This raise |
| 12 Feb 2021 | New filing | $13M | This raise |
More with JAZZ Human Performance on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.